Industry: Chemical & Material
Published Date: 2026-03-05
Pages: 98 Pages
Report ld: 6009364
Request Sample
Customized Report
Piperazine Market Size(US$)

CAGR 2026-2032
3.1%
Market Size,2032
USD 110
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Piperazine was estimated to be worth US$ 89.31 million in 2025 and is projected to reach US$ 110 million, growing at a CAGR of 3.1% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Piperazine cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Piperazine (C₄H₁₀N₂) is a vital organic chemical typically presented as a white crystalline powder, highly soluble in water and many organic solvents. Known for its mild basicity and excellent chemical reactivity, piperazine finds broad applications across pharmaceuticals, agrochemicals, rubber, resins, coatings, fiber production, and coolant industries. In the pharmaceutical sector, it serves as a crucial intermediate for synthesizing various anthelmintic drugs, especially for treating roundworm and tapeworm infections. In the chemical industry, piperazine and its derivatives are essential in the production of polymers, epoxy resin curing agents, and gas treatment aids, including CO₂ capture agents. In recent years, due to its unique structural properties, piperazine has also been increasingly utilized in drug discovery and functional material research, making it an indispensable raw material within the chemical and pharmaceutical supply chain.
In recent years, the global piperazine market has exhibited steady growth, driven by multiple converging factors. Firstly, the increasing global population and improvements in healthcare access have led to a rising demand for antiparasitic treatments, particularly in developing regions such as Africa, Southeast Asia, and South America, where parasitic infections like roundworms and tapeworms remain prevalent. This has directly fueled the market demand for piperazine-based anthelmintic drugs. Secondly, industrial applications of piperazine have expanded notably, especially in gas treatment sectors. Piperazine and its derivatives are employed as highly effective agents for carbon dioxide capture, aligning with global decarbonization efforts and green development trends. Additionally, as a critical raw material for epoxy resin curing agents, piperazine is seeing growing demand in high-performance composite materials used in aerospace, automotive, and advanced manufacturing industries.
The Asia-Pacific region, particularly China, dominates the production and consumption landscape, collectively accounting for over 45% of the global market share. China's comprehensive chemical supply chain infrastructure and relatively lower production costs position it as a key exporter of piperazine worldwide. In contrast, the United States and Europe mainly focus on pharmaceutical-grade and high-end specialty chemical segments, where requirements for product purity, quality consistency, and environmental compliance are more stringent.
Notably, increasingly stringent environmental regulations have significantly impacted the development of the piperazine market. Initiatives such as the EU's REACH Regulation, the U.S. EPA guidelines, and China's green transformation policies for the chemical industry are compelling manufacturers to upgrade production processes, minimize harmful by-products, enhance product purity, and adopt greener and safer raw materials. Moreover, research into bio-based piperazine and ultra-high-purity piperazine is accelerating, and these segments are expected to create new competitive dynamics in the coming years.
Looking forward, the global piperazine market is poised for sustained growth, driven by expanding applications in pharmaceuticals, environmental solutions, and advanced materials. Leading companies such as BASF, Dow Chemical, Yantai Hengyuan, and Nanjing Special Chemical are actively expanding production capacities and upgrading product portfolios to capture emerging opportunities. Strategic focus areas will include innovation in eco-friendly production technologies, exploration of high-value downstream applications, and expansion into untapped markets where healthcare infrastructure and industrial needs are evolving rapidly.
This report provides a comprehensive view of the global market for Piperazine, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Piperazine market size, estimations, and forecasts are presented in terms of sales volume (MT) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Piperazine.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Piperazine manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Piperazine sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Piperazine sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Piperazine Product Introduction
1.2 Global Piperazine Market Size Forecast
1.2.1 Global Piperazine Sales Value (2021–2032)
1.2.2 Global Piperazine Sales Volume (2021–2032)
1.2.3 Global Piperazine Sales Price (2021–2032)
1.3 Piperazine Market Trends & Drivers
1.3.1 Piperazine Industry Trends
1.3.2 Piperazine Market Drivers & Opportunities
1.3.3 Piperazine Market Challenges
1.3.4 Piperazine Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Piperazine Players Revenue Ranking (2025)
2.2 Global Piperazine Revenue by Company (2021–2026)
2.3 Global Piperazine Sales Volume Ranking of Players (2025)
2.4 Global Piperazine Sales Volume by Company (2021–2026)
2.5 Global Piperazine Average Price by Company (2021–2026)
2.6 Key Manufacturers Piperazine Manufacturing Base and Headquarters
2.7 Key Manufacturers Piperazine Product Offerings
2.8 Key Manufacturers Start of Mass Production of Piperazine
2.9 Piperazine Market Competitive Analysis
2.9.1 Piperazine Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Piperazine Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Piperazine revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Piperazine Market Classification
3.1 Introduction by Type
3.1.1 Anhydrous Piperazine
3.1.2 68 Piperazine
3.1.3 Other
3.1.4 Global Piperazine Sales Value by Type
3.1.4.1 Global Piperazine Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Piperazine Sales Value, by Type (2021–2032)
3.1.4.3 Global Piperazine Sales Value, by Type (%), 2021–2032
3.1.5 Global Piperazine Sales Volume by Type
3.1.5.1 Global Piperazine Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Piperazine Sales Volume, by Type (2021–2032)
3.1.5.3 Global Piperazine Sales Volume, by Type (%), 2021–2032
3.1.6 Global Piperazine Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical Industry
4.1.2 Chemical Industry
4.2 Global Piperazine Sales Value by Application
4.2.1 Global Piperazine Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Piperazine Sales Value, by Application (2021–2032)
4.2.3 Global Piperazine Sales Value, by Application (%), 2021–2032
4.3 Global Piperazine Sales Volume by Application
4.3.1 Global Piperazine Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Piperazine Sales Volume, by Application (2021–2032)
4.3.3 Global Piperazine Sales Volume, by Application (%), 2021–2032
4.4 Global Piperazine Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Piperazine Sales Value by Region
5.1.1 Global Piperazine Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Piperazine Sales Value by Region (2021–2026)
5.1.3 Global Piperazine Sales Value by Region (2027–2032)
5.1.4 Global Piperazine Sales Value by Region (%), 2021–2032
5.2 Global Piperazine Sales Volume by Region
5.2.1 Global Piperazine Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Piperazine Sales Volume by Region (2021–2026)
5.2.3 Global Piperazine Sales Volume by Region (2027–2032)
5.2.4 Global Piperazine Sales Volume by Region (%), 2021–2032
5.3 Global Piperazine Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Piperazine Sales Value, 2021–2032
5.4.2 North America Piperazine Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Piperazine Sales Value, 2021–2032
5.5.2 Europe Piperazine Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Piperazine Sales Value, 2021–2032
5.6.2 Asia Pacific Piperazine Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Piperazine Sales Value, 2021–2032
5.7.2 South America Piperazine Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Piperazine Sales Value, 2021–2032
5.8.2 Middle East & Africa Piperazine Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Piperazine Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Piperazine Sales Value and Sales Volume
6.2.1 Key Countries/Regions Piperazine Sales Value, 2021–2032
6.2.2 Key Countries/Regions Piperazine Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Piperazine Sales Value, 2021–2032
6.3.2 United States Piperazine Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Piperazine Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Piperazine Sales Value, 2021–2032
6.4.2 Europe Piperazine Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Piperazine Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Piperazine Sales Value, 2021–2032
6.5.2 China Piperazine Sales Value by Type (%), 2025 vs 2032
6.5.3 China Piperazine Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Piperazine Sales Value, 2021–2032
6.6.2 Japan Piperazine Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Piperazine Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Piperazine Sales Value, 2021–2032
6.7.2 South Korea Piperazine Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Piperazine Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Piperazine Sales Value, 2021–2032
6.8.2 Southeast Asia Piperazine Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Piperazine Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Piperazine Sales Value, 2021–2032
6.9.2 India Piperazine Sales Value by Type (%), 2025 vs 2032
6.9.3 India Piperazine Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Akzo Nobel
7.1.1 Akzo Nobel Company Information
7.1.2 Akzo Nobel Introduction and Business Overview
7.1.3 Akzo Nobel Piperazine Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Akzo Nobel Piperazine Product Offerings
7.1.5 Akzo Nobel Recent Developments
7.2 Dow Chemicals
7.2.1 Dow Chemicals Company Information
7.2.2 Dow Chemicals Introduction and Business Overview
7.2.3 Dow Chemicals Piperazine Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Dow Chemicals Piperazine Product Offerings
7.2.5 Dow Chemicals Recent Developments
7.3 BASF
7.3.1 BASF Company Information
7.3.2 BASF Introduction and Business Overview
7.3.3 BASF Piperazine Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 BASF Piperazine Product Offerings
7.3.5 BASF Recent Developments
7.4 Tosoh
7.4.1 Tosoh Company Information
7.4.2 Tosoh Introduction and Business Overview
7.4.3 Tosoh Piperazine Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Tosoh Piperazine Product Offerings
7.4.5 Tosoh Recent Developments
7.5 Delamine
7.5.1 Delamine Company Information
7.5.2 Delamine Introduction and Business Overview
7.5.3 Delamine Piperazine Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Delamine Piperazine Product Offerings
7.5.5 Delamine Recent Developments
7.6 Nippon Nyukazai
7.6.1 Nippon Nyukazai Company Information
7.6.2 Nippon Nyukazai Introduction and Business Overview
7.6.3 Nippon Nyukazai Piperazine Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Nippon Nyukazai Piperazine Product Offerings
7.6.5 Nippon Nyukazai Recent Developments
7.7 Diamines And Chemicals Limited (DACL)
7.7.1 Diamines And Chemicals Limited (DACL) Company Information
7.7.2 Diamines And Chemicals Limited (DACL) Introduction and Business Overview
7.7.3 Diamines And Chemicals Limited (DACL) Piperazine Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Diamines And Chemicals Limited (DACL) Piperazine Product Offerings
7.7.5 Diamines And Chemicals Limited (DACL) Recent Developments
7.8 Hebei Hejia Pharmaceutical Group
7.8.1 Hebei Hejia Pharmaceutical Group Company Information
7.8.2 Hebei Hejia Pharmaceutical Group Introduction and Business Overview
7.8.3 Hebei Hejia Pharmaceutical Group Piperazine Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Hebei Hejia Pharmaceutical Group Piperazine Product Offerings
7.8.5 Hebei Hejia Pharmaceutical Group Recent Developments
7.9 Shaoxing Xingxin New Materials Co.,Ltd
7.9.1 Shaoxing Xingxin New Materials Co.,Ltd Company Information
7.9.2 Shaoxing Xingxin New Materials Co.,Ltd Introduction and Business Overview
7.9.3 Shaoxing Xingxin New Materials Co.,Ltd Piperazine Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Shaoxing Xingxin New Materials Co.,Ltd Piperazine Product Offerings
7.9.5 Shaoxing Xingxin New Materials Co.,Ltd Recent Developments
8 Industry Chain Analysis
8.1 Piperazine Industrial Chain
8.2 Piperazine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Piperazine Sales Model
8.5.2 Sales Channels
8.5.3 Piperazine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Piperazine market size was US$ 89.31 million in 2025 and is forecast to reach a readjusted size of US$ 110 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 79
USD 4250.00
(Single User License)
The global Piperazine market is projected to grow from US$ 89.31 million in 2025 to US$ 110 million by 2032, at a CAGR of 3.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 133
USD 4900.00
(Single User License)
The global Piperazine market was valued at US$ 89.31 million in 2025 and is anticipated to reach US$ 110 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 134
USD 2900.00
(Single User License)
The global Piperazine market is projected to grow from US$ 87.7 million in 2024 to US$ 107 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 144
USD 4900.00
(Single User License)
The global market for Piperazine was estimated to be worth US$ 87.7 million in 2024 and is forecast to a readjusted size of US$ 107 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-05-01
Pages: 109
USD 3950.00
(Single User License)
The global Piperazine market is projected to grow from US$ 89.3 million in 2025 to US$ 107 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.1% during the forecast period.
Published Date: 2025-05-01
Pages: 143
USD 4900.00
(Single User License)
The global Piperazine market size was US$ 87.7 million in 2024 and is forecast to a readjusted size of US$ 107 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-05-01
Pages: 78
USD 4250.00
(Single User License)
The global market for Piperazine was valued at US$ 87.7 million in the year 2024 and is projected to reach a revised size of US$ 107 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-05-01
Pages: 92
USD 2900.00
(Single User License)
The global market for Piperazine was estimated to be worth US$ 87.7 million in 2024 and is forecast to a readjusted size of US$ 101 million by 2031 with a CAGR of 2.1% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 125
USD 3950.00
(Single User License)
Piperazine (PIP; CAS 110-85-0) is a cyclic ethylene amine with two secondary amine groups. In its pure form, PIP has a freezing point of 106°C and a boiling point of 148°C.
Published Date: 2024-04-15
Pages: 105
USD 4900.00
(Single User License)
The global Piperazine market size was US$ 89.31 million in 2025 and is forecast to reach a readjusted size of US$ 110 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 79
The global Piperazine market is projected to grow from US$ 89.31 million in 2025 to US$ 110 million by 2032, at a CAGR of 3.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 133
The global Piperazine market was valued at US$ 89.31 million in 2025 and is anticipated to reach US$ 110 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-03-05
Pages: 134
The global Piperazine market is projected to grow from US$ 87.7 million in 2024 to US$ 107 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 144
The global market for Piperazine was estimated to be worth US$ 87.7 million in 2024 and is forecast to a readjusted size of US$ 107 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-05-01
Pages: 109
The global Piperazine market is projected to grow from US$ 89.3 million in 2025 to US$ 107 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.1% during the forecast period.
Published: 2025-05-01
Pages: 143
The global Piperazine market size was US$ 87.7 million in 2024 and is forecast to a readjusted size of US$ 107 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-05-01
Pages: 78
The global market for Piperazine was valued at US$ 87.7 million in the year 2024 and is projected to reach a revised size of US$ 107 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-05-01
Pages: 92
The global market for Piperazine was estimated to be worth US$ 87.7 million in 2024 and is forecast to a readjusted size of US$ 101 million by 2031 with a CAGR of 2.1% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 125
Piperazine (PIP; CAS 110-85-0) is a cyclic ethylene amine with two secondary amine groups. In its pure form, PIP has a freezing point of 106°C and a boiling point of 148°C.
Published: 2024-04-15
Pages: 105
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now